✦ LIBER ✦

Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas

✍ Scribed by V. Polo; A. Saibene; A. E. Pontiroli

Publisher: Springer
Year: 1998
Tongue: English
Weight: 192 KB
Volume: 35
Category: Article
ISSN: 0940-5429
DOI: 10.1007/s005920050103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined sulphonylurea and low dose biph

Combined sulphonylurea and low dose biphasic insulin improves metabolic control in Type 2 diabetes mellitus

✍ Mitchell, TH ;Henry, M ;Klocker, N ;Stafford, M ;Reuter, M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

## Abstract In this study we evaluated which injection time is preferable: morning or evening insulin in the combination glibenclamide plus a single low‐dose injection of biphasic insulin (Insuman Combitard 25/75) in Type 2 patients with secondary failure to sulphonylurea treatment. Forty one patie

Effects of glipizide GITS and glibenclam

Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes

✍ Eugene H. Go; Marinella Kyriakidou-Himonas; Michael Berelowitz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

Effects of the combination of insulin an

Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. Tötterman; F. Fyhrqvist; L. Groop 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa

A combination of once daily insulin and

A combination of once daily insulin and glibenclamide therapy in patients with type 2 diabetes and secondary drug failure

✍ Fonseca, V A ;D'Souza, V. ;Bell, J L ;Dandona, P 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

## Abstract Twenty eight patients with non‐insulin‐dependent diabetes mellitus (NIDDM) who were not adequately controlled with maximum doses of sulphonylureas and metformin (Group I; n=13) or with insulin injections (Group II; n=15) were treated with a combination of insulin injections in the morni

Well-being and symptoms in elderly Type

Well-being and symptoms in elderly Type 2 diabetes patients with poor metabolic control: Effect of insulin treatment

✍ Tovi, J ;Engfeldt, P 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

## Abstract The effect of improved metabolic control on well‐being and symptoms, with insulin therapy, was investigated in elderly patients with Type 2 diabetes. They had secondary failure on oral therapy, but were without decompensation. A selfadministered well‐being questionnaire was used. Patien

Effects of a combination of bedtime inte

Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents

✍ M. Krempf; T. Godeau; S. Ranganathan; P. Blanchard; P. Ritz; B. Charbonnel 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 603 KB

The effect of a subcutaneous injection of an intermediate-acting insulin at bedtime combined with glibenclamide has been evaluated in 16 non-insulin-diabetic patients with secondary failure to respond to oral agents. The patients showed poor metabolic control (HbA1 greater than 11%) after two months